Abounoori M, Pourazizi M, Kashkouli M, Akha O, Jafari R, Movahedirad M
BMJ Open Ophthalmol. 2024; 9(1.
PMID: 39694546
PMC: 11683961.
DOI: 10.1136/bmjophth-2024-001744.
Pekarova K, Schovanek J, Dohnal R, Radvansky Jr M, Karasek D, Karhanova M
Endocrine. 2024; 87(3):1112-1119.
PMID: 39604543
PMC: 11845400.
DOI: 10.1007/s12020-024-04108-4.
Liu Y, Li M, Chen H, Liu W, Hu M, Hu F
Sci Rep. 2024; 14(1):25810.
PMID: 39468140
PMC: 11519562.
DOI: 10.1038/s41598-024-76018-4.
Souri Z, Pakdel F
J Ophthalmic Vis Res. 2024; 19(3):368-380.
PMID: 39359534
PMC: 11443990.
DOI: 10.18502/jovr.v19i3.15047.
Jin M, Kim C, Jeon M, Kim W, Kim T, Kim W
Endocrinol Metab (Seoul). 2024; 39(4):579-589.
PMID: 38778479
PMC: 11375307.
DOI: 10.3803/EnM.2024.1918.
The Role of Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population.
Yaylacioglu Tuncay F, Serbest Ceylanoglu K, Guntekin Ergun S, Ergun G, Konuk O
Turk J Ophthalmol. 2024; 54(2):69-75.
PMID: 38645270
PMC: 11034539.
DOI: 10.4274/tjo.galenos.2024.37897.
An ensemble deep learning diagnostic system for determining Clinical Activity Scores in thyroid-associated ophthalmopathy: integrating multi-view multimodal images from anterior segment slit-lamp photographs and facial images.
Yan C, Zhang Z, Zhang G, Liu H, Zhang R, Liu G
Front Endocrinol (Lausanne). 2024; 15:1365350.
PMID: 38628586
PMC: 11019375.
DOI: 10.3389/fendo.2024.1365350.
The evaluation of retrobulbar fat tissue in Graves' orbitopathy with shear-wave ultrasound elastography.
Gunes I, Yilmaz H, Onal E
Int Ophthalmol. 2024; 44(1):13.
PMID: 38321200
DOI: 10.1007/s10792-024-02962-9.
Prevalence, Incidence, and Clinical Characteristics of Thyroid Eye Disease in Japan.
Watanabe N, Kozaki A, Inoue K, Narimatsu H, Shinohara M, LoPresti M
J Endocr Soc. 2023; 8(1):bvad148.
PMID: 38075564
PMC: 10701629.
DOI: 10.1210/jendso/bvad148.
Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease.
Zloto O, Rosset A, Priel A, Landau-Prat D, Cukierman-Yaffe T, Shavit R
Eye (Lond). 2023; 38(4):687-690.
PMID: 37821543
PMC: 10920676.
DOI: 10.1038/s41433-023-02748-w.
Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.
Muller I, Consonni D, Crivicich E, Di Marco F, Curro N, Salvi M
J Clin Endocrinol Metab. 2023; 109(2):516-526.
PMID: 37622279
PMC: 10795895.
DOI: 10.1210/clinem/dgad501.
The Changes in Ocular Biomechanical Response Parameters and Intraocular Pressure After Surgical Treatment for Thyroid Eye Disease.
Hsia Y, Wei Y, Liao S
Invest Ophthalmol Vis Sci. 2023; 64(10):31.
PMID: 37494009
PMC: 10382999.
DOI: 10.1167/iovs.64.10.31.
Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review.
Shahraki K, Pak V, Najafi A, Shahraki K, Boroumand P, Sheervalilou R
Noncoding RNA Res. 2023; 8(3):426-450.
PMID: 37324526
PMC: 10265490.
DOI: 10.1016/j.ncrna.2023.04.001.
Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves' orbitopathy.
Park J, Kim J, Kim S, Choi H
Front Endocrinol (Lausanne). 2023; 14:1153312.
PMID: 37223049
PMC: 10200942.
DOI: 10.3389/fendo.2023.1153312.
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
Taylor P, Rajendram R, Hanna S, Wilson V, Pell J, Li C
J Clin Endocrinol Metab. 2023; 108(10):2615-2625.
PMID: 36971324
PMC: 10505546.
DOI: 10.1210/clinem/dgad084.
Assessment of Choroidal Vascularity in Inactive Thyroid Associated Orbitopathy.
Pehlivanoglu S, Aksoy F, Karabulut G, Tunc U, Fazil K, Artunay O
Beyoglu Eye J. 2023; 8(1):38-44.
PMID: 36911212
PMC: 9993418.
DOI: 10.14744/bej.2022.04900.
Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.
Jin M, Jang A, Kim C, Kim T, Kim W, Shong Y
Eur Thyroid J. 2023; 12(2).
PMID: 36826832
PMC: 10083656.
DOI: 10.1530/ETJ-22-0226.
Update on the surgical management of Graves' orbitopathy.
Baeg J, Choi H, Kim C, Kim H, Jang S
Front Endocrinol (Lausanne). 2023; 13:1080204.
PMID: 36824601
PMC: 9941741.
DOI: 10.3389/fendo.2022.1080204.
Hypo vs. hyperthyroid eye disease: is there any difference?.
Eshraghi B, Pourazizi M, Abbasi M, Mohammadbeigy I
BMC Ophthalmol. 2023; 23(1):58.
PMID: 36765316
PMC: 9912537.
DOI: 10.1186/s12886-023-02806-7.
Recurrence of Exophthalmos after 10 Years from Orbital Floor Decompression for Dysthyroid Orbitopathy: A Case Report.
Bonavolonta P, Togo G, Fossataro F, Romano A, Abbate V, Iaconetta G
Indian J Otolaryngol Head Neck Surg. 2023; 74(Suppl 3):4673-4675.
PMID: 36742715
PMC: 9895134.
DOI: 10.1007/s12070-021-03003-y.
